Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat

Diabetes

Volumn 47, Issue 3, 1998, Pages 401-406

  Hammes, Hans Peter ^a   Lin, Jihong ^a   Bretzel, Reinhard G ^a   Brownlee, Michael ^b   Breier, Georg ^c  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; RETINA GANGLION CELL; RETINA NEOVASCULARIZATION;

ANIMALS; BLOTTING, WESTERN; COHORT STUDIES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOKINES; MALE; RATS; RATS, WISTAR; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, MITOGEN; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RETINA; RNA, MESSENGER; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031939649     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.3.401     Document Type: Article

References (42)

1. Moss SE, Klein R, Klein BE: Ten-year incidence of visual loss in a diabetic population. Ophthalmology 101:1061-1070,1994
2. Engerman RL: The pathogenesis of diabetic retinopathy. Diabetes 38:1203-1206, 1989
3. Litte HL: Proliferative diabetic retinopathy: pathogenesis and treatment In Diabetic Retinopathy. Little HL, Jack RL, Patz A, Forsham PH, Eds. New York, Thieme-Stratton, 1983, p. 257-273
4. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487,1994
5. Meyer-Schwickerath R, Pfeiffer A, Blum WF: Vitreous levels of the insulinlike growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease: studies in nondiabetic and diabetic subjects. J Clin Invest 92:2620-2625,1993
6. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LEH: Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 92:905-909, 1995
7. Smith LEH, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA: Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101-111, 1994
8. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, Smith LEH: Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGFreceptor chimeric proteins. Proc Natl Acad Sci USA 92:10457-10461,1995
9. Robinson GS, Pierce EA, Rook SL, Foley ED, Webb R, Smith LEH: Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci USA 93:4851-4856, 1996
10. deVries C, Escobedo J, Ueno H, Houck K, Ferrara N, Williams LT: The fmslike tyrosine kinase: a receptor for vascular endothelial growth factor. Science 255:989-991,1992
11. Terman BI, Vermazen MD, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Bohlen P: Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Commun 34:1578-1586,1992
12. Millauer B, Wizigmann-Voos S, Schnurcn H, Martinez R, Moller NP, Risau W, Ullrich A; High affinity VEGF binding and developmental expression suggest flk1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835-846,1993
13. Breier G, Clauss M, Risau W: Coordinate expression of vascular endothelial growth factor receptor 1 (fit 1) and its ligand suggests a paracrine regulation of murine vascular development. Dev Dyn 204:228-239, 1995
14. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW: The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 12:1806-1814,1991
15. Guerrin M, Moukadiri H, Chollet P, Moro F, Dutt K, Malecaze F, Plouet J: Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cell Physiol 164:385-394,1995
16. Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA: Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 113:1538-1544,1995
17. Leung DW, Cachianes G, Kuang W-J, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309,1980
18. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT: Vascular permeability factor an endothelial cell mitogen related to PDGF. Science 246:1309-1312,1989
19. Senger DR, Perruzzi CA, Feder J, Dvorak HF: A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46:5629-5632,1986
20. Pe'er J, Shweiki D, Itin A, Hemo I, Gnessin H, Keshet E: Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest 72:638-645,1995
21. Shima DT, Deutsch U, D'Amore PA: Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett 370:203-208,1995
22. Ikeda E, Achen MG, Breier G, Risau W: Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells .J Biol, Chem 270:19761-19766,1995
23. Breier G, Albrecht U, Sterrer S, Risau W: Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114:521-532,1992
24. Plate KH, Breier G, Weich HA, Risau W: Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 359:845-448,1992
25. Cogan DG, Toussaint D, Kuwabara T Retinal vascular pattern. IV. Diabetic retinopathy. Arch Ophthalmol 66:366-378,1961
26. Engerman RL: Animal models of diabetic retinopathy. Trans Am Acad Ophthalmol Otolaryngol 81:710-715,1976
27. Hammes HP, Weiss A, Führer D, Krämer HJ, Papavassilis C, Grimminger F: Acceleration of experimental diabetic retinopathy by Ω-3 fatty acids. Diabetologia 39:251-255,1996
28. Alonso S, Minty A, Bourlet Y, Buckingham M: Comparison of three actin-coding sequences in the mouse: evolutionary relationships between the actin genes of warm-blooded vertebrates. J Mol Evol 23:11-22,1986
29. Brown LF, Detmar M, Tognazzi K, Abu-Jawdeh G, Iruela-Arispe ML: Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor, Lab Invest 76:245-255,1997
30. Yang K, Cepko CL: flk-1, a receptor for vascular endothelial growth factor (VEGF), is expressed by retinal progenitor cells. J Neurosci 16:6089-6099,1996
31. Kuroki M, Voest EE, Amano S, Beerepoot LV, Takashima S, Tolentino M, Kim RY, Rohan RM, Yeo K-T, Adamis AP: Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest 98:1667-1675,1996
32. Armstrong D, al Awadi F: Lipid peroxidation and retinopathy in streptozotocininduced diabetes. Free Radic Biol Med 11:433-436,1991
33. Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K: The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab Invest 74:819-825,1996
34. Engerman R, Finkelstein D, Aguirre G, Diddie KR, Fox RR, Frank RN, Varma SD: Ocular complications. Diabetes 31 (Suppl. l):82-88,1982
35. Reynaud X, Dorey CK: Extraretinal neovascularization induced by hypoxic episodes in the neonatal rat. Invest Ophthalmol Vis Sci 35:3169-3177,1994
36. Penn JS, Henry MM, Tolman BL Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat. Pediatr Res 36:724-731,1994
37. Charnock-Jones DS, Sharkey AM, Boocock CA, Ahmed A, Plevin R, Ferrara N, Smith SK: Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. Biol Reprod 51:524-530,1994
38. Liu B, Earl M, Baban D, Shoaibi M, Fabra A, Kerr DJ, Seymour LW: Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF. Biochem Biophys Res Commun 217:721-727, 1995
39. Boocock CA, Charnock-Jones DS, Sharkey AM, McLaren J, Barker PJ, Wright KA, Twentyman PR, Smith SK: Expression of vascular endothelial growth factor and its receptors fit and KDR in ovarian carcinoma J Natl Cancer Inst 87:506-516, 1995
40. Bednarz J, Weich HA, Rodokanaki-von-Schrenck A, Engelmann K: Expression of genes coding growth factors and growth factor receptors in differentiated and dedifferentiated human corneal endothelial cells. Cornea 14:372-381, 1995
41. Guerrin M, Moukadiri H, Chollet P, Moro F, Dutt K, Malecaze F, Plouet J: Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cell Physiol 164:385-394,1995
42. Hammes HP, Federoff HJ, Brownlee M: Nerve growth factor (NGF) prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol Med 5:527-534,1995